Outcome Prediction Using Radiomics for Irinotecan-TACE in Colorectal Liver Metastases: Insights from the Prospective CIREL Study - Summary - MDSpire

Outcome Prediction Using Radiomics for Irinotecan-TACE in Colorectal Liver Metastases: Insights from the Prospective CIREL Study

  • By

  • Zuhir Bodalal

  • Francisco Javier Mendoza Ferradás

  • Olga Maxouri

  • Roberto Iezzi

  • Aleksandar Gjoreski

  • Stavros Spiliopoulos

  • Zoltan Bansaghi

  • Belarmino Gonçalves

  • Bleranda Zeka

  • Nathalie Kaufmann

  • Julien Taieb

  • Regina Beets-Tan

  • Philippe L. Pereira

  • Fernando Gómez Muñoz

  • April 29, 2026

  • 0 min

Share

Objective:

Consider adding the significance of the study in the context of existing treatments.

Key Findings:
  • Add quantitative results or statistics to enhance credibility.
Interpretation:

Elaborate on how radiomics specifically enhances personalized treatment.

Limitations:
  • Include potential solutions or future directions to address biases.
Conclusion:

Reiterate the implications for clinical practice more explicitly.

Original Source(s)

Outcome Prediction Using Radiomics for Irinotecan-TACE in Colorectal Liver Metastases: Insights from the Prospective CIREL Study

  • by Zuhir Bodalal, Francisco Javier Mendoza Ferradás, Olga Maxouri, Roberto Iezzi, Aleksandar Gjoreski, Stavros Spiliopoulos, Zoltan Bansaghi, Belarmino Gonçalves, Bleranda Zeka, Nathalie Kaufmann, Julien Taieb, Regina Beets-Tan, Philippe L. Pereira, Fernando Gómez Muñoz

  • April 29, 2026

Related Content

Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies

Visceral fat area and blood lipids in colorectal cancer: predictors of surgical risk and prognosis

Abdominoperineal pull-through with delayed coloanal anastomosis for pelvic anastomotic failure—a systematic review